Sanofi SA (SAN) - Stock Price & Dividends

Exchange: Euronext Paris • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000120578

(PA:SAN Stock) Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Sanofi SA (SAN) - Stock Price & Dividends

SAN Stock Overview

Market Cap in USD 115,544m
Sector Healthcare
Industry Drug Manufacturers - General
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception

SAN Stock Ratings

Fundamental -
Dividend 7.42
Growth 5y 4.63
Rel. Performance vs Sector -0.84
Analysts -
Fair Price Total Ret. 95.50
Fair Price DCF -

SAN Dividends

Yield 12m 4.09%
Yield on Cost 5y 5.94%
Dividends CAGR 5y 3.01%
Payout Consistency 99.8%

SAN Growth Ratios

Growth 12m -0.19%
Growth Correlation 12m -8%
Growth Correlation 3m 22%
CAGR 5y 7.61%
CAGR / Mean Drawdown 1.03
Sharpe Ratio 12m -0.20
Alpha vs SP500 12m -14.94
Beta vs SP500 5y weekly 0.45
CAPM 6.46%
Average Daily Range 2m 1.47%
Regime Oscillator 24.54
Volatility GJR Garch 1y 19.89%
Price / SMA 50 -3.49%
Price / SMA 200 -7.54%
Current Volume 2181.7k
Average Volume 20d 1410.1k
What is the price of SAN stocks?
As of February 21, 2024, the stock is trading at EUR 87.13 with a total of 2,181,693 shares traded.
Over the past week, the price has changed by +1.68%, over one month by -7.35%, over three months by +2.00% and over the past year by +1.43%.
Why is SAN stock down?
Check with which Index or Commodity SAN has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return SAN Return S&P 500
1 Month -7.35% 2.97%
3 Months 2.00% 9.80%
12 Months 1.43% 26.37%
What is the forecast for SAN stock price target?
According to ValueRays Forecast Model, SAN Sanofi SA will be worth about 103.1 in February 2025.
Issuer Forecast Upside
Wallstreet Target Price 104.9 20.4%
Analysts Target Price - -
ValueRay Target Price 103.1 18.4%